• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Examining Consumer Cost Sharing and a Precision Benefit Design With Dr Mark Fendrick

Podcast

Current policies being employed to limit spending can have serious consequences for patients, but a different benefit design approach could present an alternative strategy.

Current policies being employed to limit spending can have serious consequences for patients. In the April issue of The American Journal of Managed Care® (AJMC®), A. Mark Fendrick, MD, co-authored a paper that examined the relationship between consumer cost sharing for branded antidepressants and the initiation of branded therapy among patients who were filling a prescription for a generic medication to treat major depressive disorder.

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Read the paper:

Listen above or through one of these podcast services:Cost Sharing and Branded Antidepressant Initiation Among Patients Treated With Generics

Related Videos
Marc S. Raab, MD, PhD, University Hospital Heidelberg
James Simon, MD – Image credit: AJMC
Lindsey Valenzuela, PharmD, APh, BCACP – screenshot by AJMC
Andrew Wolf, MD, assistant professor of neurology, University of Colorado Anschutz
Dr Brian Koffman
Paula Rodríguez-Otero, MD, PhD
Kiran Bhavaraju-Sanka, MD, UT Health San Antonio, and Beth Stein, MD, St. Joseph's Health
Dr Brian Mulherin
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.